RxDoctor Payments Data

Nancy Hale

Physician Assistant · Bardstown, KYNPI 1790735306

Payments from drug & device makers

$2,825in general payments, 2019–2025

Across 184 payments — averaging $15.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$594
  • Novo Nordisk$535
  • Amgen$427
  • Lilly USA, LLC$270
  • GSK$230
  • AstraZeneca$188
  • plus $581 from 15 others

What the payments were for

  • Food & beverage$2,825100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,825 in reported general payments places this provider in the 80th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$61,089
Medicare patients
248
Services billed
6,037

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide41$63,268
JardianceEmpagliflozin22$31,014
EliquisApixaban32$26,099
JanuviaSitagliptin Phosphate27$21,354
Repatha SureclickEvolocumab27$19,190
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$17,286
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr20$13,270
FarxigaDapagliflozin Propanediol19$11,448
Tresiba Flextouch U-100Insulin Degludec12$2,837
Doxepin Hcl14$2,621
Atorvastatin Calcium412$2,476
Levothyroxine Sodium291$1,786
Pantoprazole Sodium192$1,720
Potassium Chloride132$1,600
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,549

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$535$63,26841 claims
Boehringer IngelheimJardiance$65$31,01422 claims
GSKTrelegy Ellipta, Anoro Ellipta$230$30,55645 claims
PfizerEliquis, Paxlovid$165$27,46345 claims
AstraZenecaFarxiga$188$11,44819 claims
AbbVieSynthroid$594$97032 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Bardstown

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →